Written from the studies on PubMed, searched on 2026. nov. 11.. Every number below comes from a study listed under Sources.
The claim
Posts online say that ivermectin helps with liver and biliary tract cancer.
Where research stands
We found 3 published papers on ivermectin and liver and biliary tract cancer. They were published between 2019 and 2026. None of them is a study in people. None was a study in animals, and 1 was only in cells in the lab. 1 paper was retracted.
- 0In people
- 0In animals
- 1Only in the lab
What the studies found
We have not summed up these studies in words yet. The most important papers are listed under Sources.
Verdict
Ivermectin has been studied for liver and biliary tract cancer only in cells in the lab.
Unproven means: it was only tested in animals or cells, or there is too little or mixed data from people. How we rate claims
What this means for you: Results in animals or in cells often do not hold in people. Do not stop or change your medicines because of it. Ask your doctor before you start taking it.
Sources
- Anti-parasitic Drug Ivermectin Exhibits Potent Anticancer Activity Against Gemcitabine-resistant Cholangiocarcinoma In Vitro.2019 · Anticancer Res · In the lab
- Ivermectin synergizes sorafenib in hepatocellular carcinoma via targeting multiple oncogenic pathways.2022 · Pharmacol Res Perspect · RetractedRetracted
- RETRACTION: Ivermectin Synergizes Sorafenib in Hepatocellular Carcinoma via Targeting Multiple Oncogenic Pathways.2026 · Pharmacol Res Perspect · Other paper
